News by subject: Stock Sale/Buyback

Advance Auto Parts, Inc. , a leading automotive aftermarket parts provider in North America, that serves both professional installer and do-it-yourself customers, has been notified that TRC Capital Investment Corporation (TRC) has made an unsolicited...

CEL-SCI Corporation ("CEL-SCI" or the "Company") , a Phase 3 cancer immunotherapy company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. The Company expects to grant the underwriter a...

Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that it has received $15.3 million (? 14.0 million) as a result of the full disposal of...

Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated...

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquired Comsort, Inc. d/b/a MediFind ("MediFind"), a health technology company that uses advanced analytics to help patients?especially those with serious,...

Citigroup Inc. is redeeming, in whole, all $750 million aggregate liquidation preference of Series B Depositary Shares representing interests in its 5.90% Fixed Rate / Floating Rate Noncumulative Preferred Stock, Series B (the "Preferred Stock")....

Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on July 13, 2023, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

Tivic Health® Systems, Inc. ("Tivic", "Company", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it intends to offer and sell shares of its common stock in a public offering. All of...

The PG&E Fire Victim Trust (FVT) announced today the sale of 60 million shares of PG&E stock as it continues fulfilling its mission to compensate the victims of fires in Northern California from 2015 to 2018. The FVT was created in July 2020 and...

Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to two new employees. The Compensation Committee of the Board...

Scholar Rock , a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an...

Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten offering of 21,000,000 shares of its common stock at a price of $3.00 per share and, in lieu of common stock...

BlackRock Advisors, LLC ("BlackRock") released today share repurchase activity for certain BlackRock-advised closed-end funds (the "Funds") during the quarter ended June 30, 2023. The Funds have authorized open market share repurchase programs (the...

BNY Mellon Investment Adviser, Inc. announced today that BNY Mellon Municipal Income, Inc. (NYX: DMF), BNY Mellon Strategic Municipal Bond Fund, Inc. and BNY Mellon Strategic Municipals, Inc. (each, a "Fund") have successfully sold $30,225,000,...

1. PROSUS CIRCULAR AND ANNUAL GENERAL MEETING Naspers Limited ("Naspers") (JSE: NPN): Naspers shareholders (Shareholders) are referred to the joint announcement published by Naspers and Prosus N.V. (Prosus) on 27 June 2023 (the Transaction...

ShiftPixy, Inc. ("ShiftPixy" or the "Company"), a Miami-based disruptive worker engagement and management platform, today announced the pricing of its "reasonable best efforts" public offering of 2,066,667 units at a public offering price of $1.50...

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company's Board of...

BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (the "Fund") today announced that the Fund's Board of Directors has approved the Fund's quarterly tender offer (the "Tender Offer") with the following terms: Number of Shares 2.5%...

Ferguson plc (the "Company") announces today that it purchased a total of 54,894 of its ordinary shares in the period from July 3, 2023, up to and including July 7, 2023, in connection with its $3.0 billion share repurchase program. Aggregated...

Ault Alliance, Inc. , a diversified holding company, ("Ault Alliance" or the "Company"), hereby announces that the initial distribution (the "Initial Distribution") related to securities of Imperalis Holding Corp. , d/b/a TurnOnGreen, Inc....

Stratasys Ltd. (the "Company"), a leader in polymer 3D printing solutions, today confirmed that Nano Dimension Ltd. ("Nano") has increased the offer price of its unsolicited partial tender offer to acquire Stratasys ordinary shares not already...

Surf Air Mobility Inc. ("Surf Air Mobility" or "Surf Air"), a regional air travel company aiming to sustainably connect the world's communities, today announced that it anticipates its common stock will begin trading on the New York Stock Exchange...

Tivic Health® Systems, Inc. ("Tivic", "Company", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 32,500,000 shares of its common...

Tivic Health® Systems, Inc. ("Tivic", "Company", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it intends to offer and sell shares of its common stock in a public offering. All of...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of...

Kezar Life Sciences, Inc., , a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors...

Beacon (the "Company", "we," "us" or "our") today announced that it has reached an agreement with Clayton, Dubilier & Rice, LLC ("CD&R") to repurchase all of the outstanding shares of its Series A Cumulative Convertible Participating Preferred Stock...

RiverNorth Capital and Income Fund, Inc. (the "Fund") , a closed-end fund, announced the final results of its repurchase offer for up to 5% of its outstanding common shares. The repurchase offer expired at 5:00 P.M. Eastern Time on July 5, 2023....

Arrowhead Pharmaceuticals, Inc. today announced that as an inducement to entering into employment with the Company, on July 4, 2023, the Compensation Committee of the Company's Board of Directors approved "inducement" grants to 56 new employees...

Viridian Therapeutics, Inc. (the "Company" or "Viridian"), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent...

Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, granted stock options to purchase...

VBI Vaccines Inc. (VBI or the Company), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the pricing of its previously announced underwritten public offering of...

IGC Pharma, Inc. ("IGC" or the "Company") today announced a strategic investment from four investment funds managed by Bradbury Asset Management (Hong Kong) Limited ("Bradbury") who is a leading asset management firm with over $2 billion in managed...

HarborOne Bancorp, Inc. (the "Company") announced today that its Board of Directors has adopted a share repurchase program. Under the share repurchase program, which has received regulatory approval, the Company may repurchase up to 2,325,489 shares...

Ferguson plc (the "Company") announces today that it purchased a total of 46,587 of its ordinary shares in the period from June 26, 2023, up to and including June 30, 2023, in connection with its $3.0 billion share repurchase program. Aggregated...

KalVista Pharmaceuticals, Inc. , today announced that the compensation committee of KalVista's board of directors granted two newly-hired employees inducement options to purchase an aggregate of 13,000 shares of KalVista common stock on July 3, 2023...

NOTIFICATION OF TOTAL VOTING RIGHTS AND CAPITAL IN THE COMPANY In accordance with DTR 5.6.1, the Company hereby notifies the following: The Company's issued share capital as at June 30, 2023 consisted of 232,171,182 ordinary shares of 10 pence...

Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the "Company") today announced the status of the Company's own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on January 24, 2023, pursuant to...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2014 Employment...

Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that it has entered into a securities purchase...

Nextracker Inc. ("Nextracker") announced today that in connection with its previously announced underwritten offering of 14,210,511 shares of its Class A common stock ("Common Stock") offered by Nextracker and 2,289,489 shares of Common Stock...

Alliance Entertainment Holding Corporation ("Alliance Entertainment", "Company"), a distributor and wholesaler of the world's largest in stock selection of music, movies, video games, electronics, arcades, and collectibles, today announced the...

CIRCOR International, Inc. ("CIRCOR" or the "Company") today announced that it has amended its definitive merger agreement (the "Amended Agreement") with affiliates of investment funds managed by KKR (such affiliates are referred to herein as "KKR")...

NIKE, Inc. today reported financial results for its fiscal 2023 fourth quarter and full year ended May 31, 2023. Full year reported revenues were $51.2 billion, up 10 percent compared to prior year and up 16 percent on a currency-neutral basis*...

Doma Holdings, Inc. ("Doma" or the "Company") today announced that it had filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the previously announced 1-for-25 reverse...

Golden Minerals Company ("Golden Minerals", "Golden" or the "Company") is pleased to announce that it has closed its previously announced registered direct offering for the purchase and sale of an aggregate of 1,427,587 shares of common stock (or...

Ironwood Pharmaceuticals, Inc. ("Ironwood") , a GI-focused healthcare company, and VectivBio Holding AG ("VectivBio") , a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal...

NUBURU, Inc. ("NUBURU" or the "Company") , a leading innovator in high-power and high-brightness industrial blue laser technology, today announced that, subsequent to the Purchase Agreement previously announced on June 12, 2023 which raised...

Trinity Industries, Inc. ("Trinity" or the "Company") today announced that it has finalized the terms of its offering (the "Offering") of $400.0 million aggregate principal amount of 7.750% Senior Notes due 2028 (the "Notes"). Trinity anticipates...

Jefferies Financial Group Inc. : Q2 Financial Highlights Net earnings attributable to common shareholders of $12 million, or $0.05 per diluted share, including $72 million of pre-tax losses related to OpNet (formerly Linkem), a legacy merchant...